title: Structure-based repurposing of FDA-approved drugs as TNF-α inhibitors.
authors.affiliation: Centre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China. duncanl@hkbu.edu.hk
authors.forename: Chung-Hang
authors.initials: CH
authors.lastname: Leung
authors.forename: Daniel Shiu-Hin
authors.initials: DS
authors.lastname: Chan
authors.forename: Maria Hiu-Tung
authors.initials: MH
authors.lastname: Kwan
authors.forename: Zhen
authors.initials: Z
authors.lastname: Cheng
authors.forename: Chun-Yuen
authors.initials: CY
authors.lastname: Wong
authors.forename: Guo-Yuan
authors.initials: GY
authors.lastname: Zhu
authors.forename: Wang-Fun
authors.initials: WF
authors.lastname: Fong
authors.forename: Dik-Lung
authors.initials: DL
authors.lastname: Ma
mesh_terms: D001665:Binding Sites; D003198:Computer Simulation; D016208:Databases, Factual; D017277:Drug Approval; D015195:Drug Design; D057166:High-Throughput Screening Assays; D054852:Small Molecule Libraries / Q000737:chemistry*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000378:metabolism; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D054852:Small Molecule Libraries; D014409:Tumor Necrosis Factor-alpha